SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Head‐to‐head comparison between two screening systems for HB s AG , anti‐ HB c, anti‐ HCV and HIV combination immunoassays in an international, multicentre evaluation study
10 references·0 citing·36 second hop
Head‐to‐head comparison between two screening systems for HB s AG , anti‐ HB c, anti‐ HCV and HIV combination immunoassays in an international, multicentre evaluation study (2015)Head‐to‐head comparison between two scree…How safe is safe: new human immunodeficiency virus Type 1 variants missed by nucleic acid testing (2013)How safe is safe: new human i…Evaluation of two, commercial, multi‐dye, nucleic acid amplification technology tests, for HBV/HCV/HIV‐1/HIV‐2 and B19V/HAV, for screening blood and plasma for further manufacture (2012)Evaluation of two, commercial…Transfusion-transmitted infectious diseases (2009)Transfusion-transmitted infec…Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus (2008)Experience of German Red Cros…The National Blood Service (England) Approach to Evaluation of Kits for Detecting Infectious Agents (2007)The National Blood Service (E…Emerging Infectious Diseases That Threaten the Blood Supply (2006)Emerging Infectious Diseases …The cost‐effectiveness of NAT for HIV, HCV, and HBV in whole‐blood donations (2003)The cost‐effectiveness of NAT…Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population (2002)Current prevalence and incide…STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT (1986)STATISTICAL METHODS FOR ASSES…Akufo and Ibarapa (1965)Akufo and IbarapaFeasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting (1999)Infectivity of human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion (2009)International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009 (2011)First report of human immunodeficiency virus transmission via a blood donation that tested negative by 20‐minipool nucleic acid amplification in J apan (2014)The current status of nucleic acid amplification technology in transfusion‐transmitted infectious disease testing (2016)Transfusion of HIV‐infected blood products despite highly sensitive nucleic acid testing (2019)Yield of HCV and HIV‐1 NAT after screening of 3.6 million blood donations in central Europe (2002)The prevalence of hepatitis A virus and parvovirus B19 in source‐plasma donors and whole blood donors in China (2015)The Brazilian experience of nucleic acid testing to detect human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in blood donors (2018)Anti‐ HB c screening – is it worth the effort? Results of a 10‐year surveillance programme covering more than 30 million donations in Germany (2019)Measurement in Medicine: The Analysis of Method Comparison Studies (1983)Bias in meta-analysis detected by a simple, graphical test (1997)A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research (2016)Correlation Coefficients: Appropriate Use and Interpretation (2018)Recommendations for Reporting Cost-effectiveness Analyses (1996)The Risk of Transfusion-Transmitted Viral Infections (1996)Probability of Viremia with HBV, HCV, HIV, and HTLV among Tissue Donors in the United States (2004)Estimating the cost of blood: past, present, and future directions (2007)Transfusion‐associated infections: 50 years of relentless challenges and remarkable progress (2010)Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing (2004)A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)Experience of mandatory nucleic acid test (NAT) screening across all blood organizations in Germany: NAT yield versus breakthrough transmissions (2009)Nucleic acid testing for blood banks: An experience from a tertiary care centre in New Delhi, India (2013)History and Future of Nucleic Acid Amplification Technology Blood Donor Testing (2019)Donors whose blood reacts falsely positive in transfusion microbiology screening assays need not be lost to transfusion (2007)Current information on the infectious risks of allogeneic blood transfusion (2008)Hepatitis B and residual risk of infection in English and Welsh blood donors, 1996 through 2008 (2011)Blood supply under threat (2013)Prevalence and trends of markers of hepatitis B virus, hepatitis C virus and human Immunodeficiency virus in Argentine blood donors (2014)Emerging Infectious Diseases and Blood Safety: Modeling the Transfusion-Transmission Risk (2017)Prevention of transfusion-transmitted infections (2019)Current risk for transfusion transmitted infections (2007)Emerging viral threats to the Australian blood supply (2008)Modeling the transmission risk of emerging infectious diseases through blood transfusion (2012)The Kappa Statistic in Reliability Studies: Use, Interpretation, and Sample Size Requirements (2005)The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study (2010)
this work references cited by second hop

References

  • 1986STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT47,910 cited
  • 1965Akufo and Ibarapa16,856 cited
  • 2002Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population642 cited
  • 2003The cost‐effectiveness of NAT for HIV, HCV, and HBV in whole‐blood donations264 cited
  • 2008Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus189 cited
  • 2009Transfusion-transmitted infectious diseases174 cited
  • 2006Emerging Infectious Diseases That Threaten the Blood Supply109 cited
  • 2013How safe is safe: new human immunodeficiency virus Type 1 variants missed by nucleic acid testing30 cited
  • 2012Evaluation of two, commercial, multi‐dye, nucleic acid amplification technology tests, for HBV/HCV/HIV‐1/HIV‐2 and B19V/HAV, for screening blood and plasma for further manufacture27 cited
  • 2007The National Blood Service (England) Approach to Evaluation of Kits for Detecting Infectious Agents25 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work